Loading organizations...
Loading organizations...
Develops therapeutics for diseases of aging using therapeutic enzymes.
Revel Pharmaceuticals has raised $8.4M across 1 funding round.
Revel Pharmaceuticals has raised $8.4M in total across 1 funding round.
Revel Pharmaceuticals has raised $8.4M in total across 1 funding round.
Revel Pharmaceuticals's investors include Patrick Burgermeister, Starbloom Capital, Tubus.
Revel Pharmaceuticals has raised $8.4M across 1 funding round. Most recently, it raised $8.4M Seed in March 2022.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Mar 17, 2022 | $8.4M Seed | Patrick Burgermeister, Starbloom Capital | Tubus |